[Prevention and management of paravalvular leak post-transcatheter aortic valve implantation] [0.03%]
经导管主动脉瓣植入术后瓣周漏的预防和处理
Renatomaria Bianchi,Maurizio Cappelli Bigazzi,Gemma Salerno et al.
Renatomaria Bianchi et al.
During transcatheter aortic valve implantation (TAVI) the native valve is not removed but crushed. Thus, a slight prosthesis insufficiency is not uncommon and has been reported up to 25% of patients for both available types of percutaneous ...
[Aortic annulus rupture during transcatheter aortic valve implantation: complication prevention and management] [0.03%]
[经导管主动脉瓣植入术中主动脉瓣环撕裂的预防和处理]
Marco B Ancona,Lorenzo Cianfanelli,Vittorio Romano et al.
Marco B Ancona et al.
Aortic annulus rupture is a dangerous complication of transcatheter aortic valve implantation, with an overall incidence of around 1%. Ruptures can be distinguished into supra-annular, involving injuries of the sinus of Valsalva and the sin...
[Management of access site vascular complications in transcatheter aortic valve implantation] [0.03%]
经导管主动脉瓣植入的血管通路并发症管理
Tommaso Piva,Elisa Nicolini,Andi Muçaj et al.
Tommaso Piva et al.
Since its advent, transcatheter aortic valve implantation (TAVI) has experienced a continuous expansion, thanks to extraordinary clinical results and to the dramatic increase of safety, enabled by improvements of prosthesis and delivery sys...
[Optimal therapeutic management in the clinical journey of patients with heart failure] [0.03%]
心力衰竭患者临床路径中的优化治疗策略
Pietro Ameri,Antonio Francesco Amico,Alessandro Battagliese et al.
Pietro Ameri et al.
Heart failure (HF) is still characterized by high mortality rates, despite the progress achieved in terms of treatment options. With regard to the treatment of HF with reduced ejection fraction (HFrEF), the 2016 European Society of Cardiolo...
Luigi Tavazzi,Gianni Tognoni,Aldo P Maggioni
Luigi Tavazzi
Manlio Cipriani,Marco Merlo,Domenico Gabrielli et al.
Manlio Cipriani et al.
Myocarditis is an inflammatory heart disease that can occur acutely, as in acute myocarditis, or persistently, as in chronic myocarditis or chronic inflammatory cardiomyopathy. Different agents can induce myocarditis, with viruses being the...
[Renal denervation for the treatment of refractory hypertension: where are we?] [0.03%]
顽固性高血压的肾动脉交感神经消融治疗述评
Martina Chiriacò,Stefano Masi,Nicola Riccardo Pugliese et al.
Martina Chiriacò et al.
Renal denervation (RDN) is a device-based procedure historically studied in the treatment of resistant hypertension. Studies conducted over the years have produced conflicting results and its application in routine antihypertensive treatmen...
[Ischemia with no obstructive coronary artery disease: microvascular angina and vasospastic angina] [0.03%]
无冠状动脉狭窄的心绞痛：微血管性心绞痛与变异型心绞痛
Vincenzo Sucato,Salvatore Novo,Girolamo Manno et al.
Vincenzo Sucato et al.
About 40% of patients undergoing coronary angiography for chest pain with anginal features have angiographically normal or near-normal coronary arteries. It was necessary to standardize all myocardial ischemia scenarios in stable patients i...
[Diagnostic work-up and clinical management of cardiomyopathies: the operative protocol from the Cardiothoracovascular Department of Trieste, Italy] [0.03%]
[意大利三角洲心脏胸外科部门的操作方案对心脏病理学诊断和临床治疗的研究]
Marco Merlo,Chiara Cappelletto,Giulia De Angelis et al.
Marco Merlo et al.
Cardiomyopathies are primary myocardial disorders, genetically determined, with clinical onset between the third and the fifth decade of life. They represent the main causes of sudden cardiac death and heart failure in the youth. The more c...